Praised for its ‘depth and experience’, Hogan Lovells International LLP is well-equipped to advise clients in the pharmaceutical, medical device and healthcare industries, with expertise across transactional, regulatory, patent litigation and product liability matters. The firm handles collaborations, M&A and licensing transactions, and is also well-placed to advise on regulatory frameworks, compliance and agency investigations, with a particular focus on emerging technologies. The practice is also experienced in multijurisdictional patent and product liability litigation and IP lifecycle management, supported by its in-house scientific unit. The team is co-chaired by ’highly regarded’ patent litigator Stephen Bennett and regulatory specialist Jane Summerfield, who brings ’eminent’ regulatory knowledge and a commercial approach to clinical trials, marketing authorisations, and manufacturing licenses. Praised for his ‘innovative litigation strategy’, fellow co-lead Matthew Felwick leverages his scientific background in product liability and commercial disputes. Penny Powell focuses on complex commercial transactions, while Daniel Brook and Stella Wong handle patent disputes across jurisdictions.
Legal 500 redaktioneller Kommentar
Anwält*innen
Leading partners
Die stärksten Partner*innen ihres Praxisbereichs, die eine führende Rolle in signifikanten Mandaten einnehmen und weitreichende Anerkennung unter Wettbewerbern und Mandanten genießen.
Next Generation Partners
Juniorpartner*innen, die im Markt von Mandanten und Wettbewerbern anerkannt werden und in einigen Mandaten eine Schlüsselrolle einnehmen.
Leading associates
Führende Associates sind regelmäßig an zentralen Mandaten des Teams beteiligt und erhalten positives Feedback von Wettbewerbern oder Mandanten.
Elise Martin
Praxisleitung
Jane Summerfield; Stephen Bennett; Matthew Felwick
Weitere Kernanwält*innen
Penny Powell; Daniel Brook; Stella Wong; Elise Martin; Katie McConnell; Imogen Ireland; Ian Moss; Helen Poulson; Raina Hayles; Lara Knight; Lucy Ward


